Happy I could contribute to this project in a small way. If you're interested in #ESR1 / #EstrogenReceptor (ER) in breast cancer, give it a read! #brca #breastcancer

Patients with estrogen receptor–positive, #HER2 -negative advanced #BreastCancer experienced significantly longer progression-free survival when treated with an oral #CombinationTherapy that included #giredestrant, a next-generation selective #EstrogenReceptor degrader and complete antagonist.